MANILA, Philippines — A company has expressed willingness to file for a certificate product registration (CPR) of imported human-grade ivermectin before the Food and Drug Administration (FDA).
FDA Director General Eric Domingo on Tuesday said that representatives of the company, which he did not identify, have already met with drug regulators in the Philippines last week.
Domingo said Lloyd Laboratories, a local pharmaceutical firm, earlier applied for a CPR of ivermectin before the FDA.
“There is one importer who already had a meeting with our regulators last week to ask for the requirements and they said they would file for a CPR …
Keep on reading: FDA: Firm interested in applying for product registration of imported ivermectin